You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ALPHACAINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Alphacaine Hydrochloride patents expire, and what generic alternatives are available?

Alphacaine Hydrochloride is a drug marketed by Carlisle and is included in three NDAs.

The generic ingredient in ALPHACAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ALPHACAINE HYDROCHLORIDE?
  • What are the global sales for ALPHACAINE HYDROCHLORIDE?
  • What is Average Wholesale Price for ALPHACAINE HYDROCHLORIDE?
Summary for ALPHACAINE HYDROCHLORIDE
Drug patent expirations by year for ALPHACAINE HYDROCHLORIDE

US Patents and Regulatory Information for ALPHACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Carlisle ALPHACAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 084721-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Carlisle ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084720-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Carlisle ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084732-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ALPHACAINE HYDROCHLORIDE Market Analysis and Financial Projection Experimental

Lidocaine Hydrochloride Market Dynamics and Financial Trajectory: A Comprehensive Overview

Introduction to Lidocaine Hydrochloride

Lidocaine hydrochloride, a local anesthetic and anti-arrhythmic drug, is widely used in various medical procedures, including dental, surgical, and cosmetic treatments. One of the prominent formulations of lidocaine hydrochloride is Alphacaine, which is particularly popular in dentistry.

Market Size and Growth Projections

The lidocaine hydrochloride market is anticipated to experience significant growth over the coming years. Here are some key projections:

  • The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.1% from 2024 to 2029[1][3].
  • By 2032, the market is projected to reach a value of approximately USD 1.2 billion, growing at a CAGR of 5.5% from 2024 to 2032[4].

Key Drivers of Market Growth

Several factors are driving the growth of the lidocaine hydrochloride market:

  • High Prevalence of Dental Disorders: The increasing number of dental procedures and the high prevalence of dental disorders are significant drivers of the market[1].
  • COVID-19 Impact: The potential benefits of lidocaine hydrochloride in treating COVID-19 patients, such as reducing cytokines and protecting patient lungs, have boosted its demand during the pandemic period[1][3].
  • Relaxation of Surgical Regulations: The post-pandemic relaxation of strict regulations on surgical procedures has led to a resumption of services, further driving the demand for lidocaine hydrochloride[1][3].
  • Increasing Surgical and Cosmetic Procedures: The global increase in surgical and cosmetic procedures is another major driver, as lidocaine hydrochloride is extensively used in these procedures[3].

Regional Market Dynamics

The lidocaine hydrochloride market is segmented geographically, with different regions exhibiting varying growth rates:

  • North America: This region holds the largest market share due to the presence of major industry players and the high volume of surgical procedures conducted here[1][3][4].
  • Asia Pacific: This region is expected to be the fastest-growing market, with a CAGR of 5.9% during the forecast period, driven by increasing healthcare infrastructure and medical procedures[1][4].

Major Players and Competitive Landscape

The lidocaine hydrochloride market is moderately competitive, with several key players:

  • Pfizer Inc.: One of the leading companies in the market, known for its extensive product portfolio and strong market presence[1][3].
  • Merck KGaA: Another major player investing in the development of advanced products with improved safety profiles[1][3].
  • Mahendra Chemicals: Known for its strategic partnerships and collaborations to enhance geographical penetration[1].
  • Nortec Quimica: A key player focusing on product innovation and market expansion[1].

These companies are adopting strategies such as investing in the development of effective and long-acting products, improving geographical penetration through partnerships, and enhancing their market shares through competitive pricing and product differentiation.

Product Specifics: Alphacaine

Alphacaine, a formulation of lidocaine hydrochloride, is particularly notable for its use in dentistry:

  • Composition: Alphacaine is available in formulations such as lidocaine hydrochloride 2% with epinephrine 1:100,000 or 1:80,000, packaged in glass cartridges with siliconized plungers[2].
  • Benefits: It is considered the gold standard anesthetic in dentistry, highly researched, and preferred for pregnant patients. It offers benefits such as better visualization of blood reflux, comfort for the patient due to the smoothness of the siliconized plunger, and total efficacy throughout the shelf life[2].
  • Indications: Alphacaine is indicated for various dental procedures including restorative treatments, surgeries, endodontic treatments, and procedures in pediatric dentistry[2].

Financial Trajectory

The financial trajectory of the lidocaine hydrochloride market is promising:

  • Current Market Size: The market was valued at USD 752.5 million in 2023[4].
  • Future Projections: It is expected to reach USD 1.2 billion by 2032, growing at a CAGR of 5.5% from 2024 to 2032[4].
  • Segmentation: The market is segmented by dosage form, application, product type, end-user, and region. Hospitals dominate the end-user segment, accounting for the largest market revenue[4].

Challenges and Pitfalls

Despite the positive growth prospects, the market faces several challenges:

  • Potential Risks: The use of lidocaine hydrochloride is associated with potential risks, which may impact its growth trajectory. These include adverse effects such as allergic reactions and systemic toxicity[3].
  • Regulatory Hurdles: Strict regulations and the need for continuous compliance can pose challenges for market growth[3].

Key Takeaways

  • The lidocaine hydrochloride market is expected to grow significantly, driven by its extensive use in medical procedures and the relaxation of post-pandemic regulations.
  • North America holds the largest market share, while the Asia Pacific region is the fastest-growing.
  • Major players like Pfizer Inc. and Merck KGaA are driving innovation and market expansion.
  • Alphacaine, a formulation of lidocaine hydrochloride, is a gold standard anesthetic in dentistry with numerous benefits.
  • The market faces challenges related to potential risks and regulatory hurdles.

FAQs

What is the current market size of the lidocaine hydrochloride market?

The lidocaine hydrochloride market was valued at USD 752.5 million in 2023[4].

Who are the major players in the lidocaine hydrochloride market?

Major players include Pfizer Inc., Merck KGaA, Mahendra Chemicals, Nortec Quimica, and Cirondrugs[1][3].

Which region is expected to grow the fastest in the lidocaine hydrochloride market?

The Asia Pacific region is expected to grow at the highest CAGR over the forecast period[1][4].

What are the key drivers of the lidocaine hydrochloride market growth?

Key drivers include the high prevalence of dental disorders, the impact of COVID-19, relaxation of surgical regulations, and the increasing number of surgical and cosmetic procedures[1][3].

What are the potential risks associated with lidocaine hydrochloride?

Potential risks include adverse effects such as allergic reactions and systemic toxicity[3].

Sources

  1. Mordor Intelligence: Lidocaine Hydrochloride Market - Share, Trends & Size
  2. DFL: Alphacaine
  3. Mordor Intelligence: Lidocaine Hydrochloride Market Size - Mordor Intelligence
  4. Global Market Insights: Lidocaine Hydrochloride Market Size & Share Report, 2032

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.